The 2-Minute Rule for Healthcare News
Novo CEO pressed by Senate to chop costs of obesity, diabetes drugs CEO Lars Fruergaard Jørgensen instructed lawmakers the business would take into account new talks with insurers with regard to the checklist charges of Wegovy and copyright if they pledge to keep the medicines on their own formularies.Hear the report ten min This audio is automobi